Interferon-alpha-2A as a salvage treatment for hemorrhagic enteritis associated with epstein-barr virus reactivation: A case report

D. Lankenau-Vela, F. De la Garza-Salazar, P. Colunga-Pedraza, D. Jaime-Villalón

Research output: Contribution to journalArticlepeer-review

Abstract

Epstein-Barr virus [EBV] is a virus that infects almost all humans worldwide. After the acute phase of the infection, it stays in a latent form in B lymphocytes. EBV reactivation tends to occur in immunosuppressed patients. EBV reactivation may involve the gastrointestinal tract; it has been associated mainly with colitis, but hemorrhagic enteritis has been poorly reported. Treatment usually includes antivirals. However, our patient did not respond to conventional treatment, so interferon alpha-2a was given as a salvage treatment. To our knowledge, this is the first reported case of hemorrhagic enteritis associated to EBV reactivation treated successfully with interferon alpha-2a.

Original languageEnglish
Pages (from-to)129-130
Number of pages2
JournalActa Gastro-Enterologica Belgica
Volume84
Issue number1
DOIs
Publication statusPublished - 1 Jan 2021

Bibliographical note

Publisher Copyright:
© 2021, Universa Press. All rights reserved.

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Fingerprint

Dive into the research topics of 'Interferon-alpha-2A as a salvage treatment for hemorrhagic enteritis associated with epstein-barr virus reactivation: A case report'. Together they form a unique fingerprint.

Cite this